Rchr
J-GLOBAL ID:200901010714167441   Update date: Oct. 02, 2022

Yoshida Toshimichi

ヨシダ トシミチ | Yoshida Toshimichi
Affiliation and department:
Homepage URL  (1): http://www.medic.mie-u.ac.jp/pathol_matrix
Research field  (1): Experimental pathology
Research keywords  (6): テネイシン ,  再生 ,  創傷治癒 ,  がん ,  組織リモデリング ,  細胞外マトリックス
Papers (218):
  • Liu L, Fujimoto M, Nakano F, Nishikawa H, Okada T, Kawakita F, Imanaka-Yoshida K, Yoshida T, Suzuki H. Deficiency of Tenascin-C Alleviates Neuronal Apoptosis and Neuroinflammation After Experimental Subarachnoid Hemorrhage in Mice. Molecular neurobiology. 2018. 55. 11. 8346-8354
  • Kimura T, Tajiri K, Sato A, Sakai S, Wang Z, Yoshida T, Uede T, Hiroe M, Aonuma K, Ieda M, et al. Tenascin-C Accelerates Adverse Ventricular Remodeling after Myocardial Infarction by Modulating Macrophage Polarization. Cardiovascular research. 2018. 115. 3. 614-624
  • Suzuki H, Fujimoto M, Kawakita F, Liu L, Nakatsuka Y, Nakano F, Nishikawa H, Okada T, Kanamaru H, Imanaka-Yoshida K, et al. Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: Findings from basic and clinical studies. Journal of neuroscience research. 2018. 98. 1. 42-56
  • Masanao Iwamoto, Alice Okazaki, Sayaka Murata, Masaki Hirukawa, Keiichi Miyamoto, Tomohiro Murata, Eiji Ishikawa, Toshimichi Yoshida, Takashi Horiuchi. Peritoneal Dialysis Fluid-Induced Fragmentation of Golgi Apparatus as a Biocompatibility Marker. Artificial Organs. 2018. 42. 6. E90-E101
  • Aoi Hayasaki, Yasuhiro Murata, Masanobu Usui, Taemi Hibi, Takahiro Ito, Yusuke Iizawa, Hiroyuki Kato, Akihiro Tanemura, Yoshinori Azumi, Naohisa Kuriyama, et al. Clinical significance of histological effect and intratumor stromal expression of Tenascin-C in resected specimens after chemoradiotherapy for initially locally advanced unresectable pancreatic ductal adenocarcinoma. Pancreas. 2018. 47. 4. 390-399
more...
Professional career (1):
  • 医学博士 (三重大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page